drugset / Trial / NCT00803907

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

NCT00803907

Phase 4 Unknown 20 enrolled University of Sao Paulo
NaSingle-groupOpen-labelTreatment

Summary

This study aimed to prove the efficacy and safety of the use of imiquimod 5% cream in the periorbital region.

Timeline

Start
2008-12
Primary completion
2012-09
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 % Topical

Indications